News & Updates
Filter by Specialty:
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
byAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022Machine learning shows potential in detection of age-related macular degeneration
04 May 2022
Existing machine learning classifiers for age-related macular degeneration (AMD) demonstrate promising diagnostic accuracy, reports a recent meta-analysis.